For the first time, scientists have identified promising drug candidates that bind irreversibly with a notoriously ...

For the first time scientists have identified promising drug candidates that bind irreversibly with a notoriously "undruggable" cancer protein target, permanently blocking it.

Fast Company's annual list of the World's Most Innovative Companies spotlights organizations across various industries that are driving meaningful change through groundbreaking ideas and ...

No. 5 / 2025 Zealand Pharma increases its share capital as a result of the exercise of employee warrants Copenhagen, Denmark, ...

BRP, identified through peptide prediction, may revolutionize weight loss treatment, offering efficacy without the ...

A multi-peptide neoantigen cancer vaccine using relatively few antigens induced a strong immune response across multiple ...

Researchers at the Icahn School of Medicine at Mount Sinai, led by Nina Bhardwaj, MD, Ph.D., Ward-Coleman Chair in Cancer ...

Enrollment complete in Phase 2 Avail™ trial of canvuparatide in hypoparathyroidism; topline results on track for Q3 2025MBX 1416 Phase 2 trial in ...

Background Mechanical stress on the heart is commonly considered the sole stimulus explaining the synthesis and release of ...

BRP emerges as a promising peptide for weight loss, activating appetite control pathways without triggering nausea, paving ...